Cargando…
Pharmaceutical Market Access in Emerging Markets.
| Clasificación: | Libro Electrónico |
|---|---|
| Autor principal: | |
| Otros Autores: | |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
[Place of publication not identified] :
SEEd srl : SEEd,
2016.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Cover ; Colophon ; Preface; 1. Introduction to the Market Access; 1.1 Origin of the Market Access term; Market Access for goods; Application of the Market Access concept to healthcare: similarities with market economy; 1.2 Healthcare market specifics; 1.3 Market Access definition; 1.4 Market Access key concepts; What is Access; What is Value; Market Access and the structure of healthcare market; 1.5 Cultural specificities of Market Access; 1.6 Market Access from payers perspective; The payers of healthcare; Market Access tools to control drug expenditure; The Value assessment by payers.
- The link between HTA and Pricing & Reimbursement conditionsNon-HTA tools that affect pricing; 1.7 Market Access Agreements; Definition; Taxonomy; The future; 1.8 References; 1.9 To know more; 2. Market Access in Asian countries; 2.1 Overview on the Healthcare Systems and Healthcare Policies; South Korea; China; Thailand; 2.2 Recent Healthcare Policies; Thailand; South Korea; China; 2.3 Pathways of Market Access; South Korea; China; Thailand; 2.4 Challenges and catalyzers for Market Access; 2.5 Market Outlook; 2.6 References; 2.7 To know more; 3. Market Access in South American Countries.
- 3.1 Introduction3.2 General economic outlook; 3.3 Health Sector; 3.4 Pharmaceutical Markets; 3.5 Health Technology Agencies; The History of HTA in Latin America; Red ETSA
- Pan-American Health Organization (PAHO/WHO); How the future looks? ; 3.6 Market access; Mexico; Colombia; Access to Mexico; Access to Colombia; 3.7 Final Comments; 3.8 To know more; 4. Market Access in South Eastern Europe Countries; 4.1 Introduction; Historical influence and heritage of healthcare sector; 4.2 General Outlook of Healthcare System and Health Policies; Albania; Bosnia and Herzegovina; Kosovo; Macedonia, FYR.
- MontenegroSerbia; 4.3 Pathways of Market Access (Regulation and Reimbursement); Albania; Kosovo; 4.4 Mapping and structure of Decision Makers; Albania; Bosnia and Herzegovina; Macedonia, FYR; Montenegro; Serbia; 4.5 Challenges and catalyzers for Market Access and Look-up for Near Future; Albania; Bosnia and Herzegovina; Kosovo; Macedonia, FYR; Montenegro; Serbia; 4.6 References; 5. Market Access in North Eastern Europe Countries; 5.1 General Outlook of Healthcare System and Health Policies; Russia; Poland; Ukraine; 5.2 Pathways of Market Access; Russia; Poland; Ukraine.
- 5.3 Mapping and Structure of Decision MakersRussia; Poland; Ukraine; 5.4 Challenges and Catalyzers for Market Access; Russia; Poland; Ukraine; 5.5 Good Examples from Successful Market Access Strategies; Russia; Poland; Ukraine; 5.6 Look up for near future; Russia; Poland; Ukraine; 5.7 References; 6. Market Access in the United Arab Emirates and Selected Middle Eastern Countries; 6.1 The Middle East; The Gulf Cooperation Council; 6.2 Introduction; 6.3 General Outlook of Healthcare System and Health Policies in the UAE and Other ME Countries; The United Arab Emirates (UAE).